Making Drug Treatment Work : Opportunities and Challenges towards an Evidence- and Rights-Based Approach
Compulsory drug detention centers (CDDCs) are common throughout Asia. However, medical treatments for substance use disorders, such as opioid agonist treatment (OAT), are generally unavailable in these settings. In this report, the authors compare...
| Main Authors: | , , , , , , , |
|---|---|
| Language: | English |
| Published: |
World Bank, Washington, DC
2018
|
| Subjects: | |
| Online Access: | http://documents.worldbank.org/curated/en/444171526625911078/Making-drug-treatment-work-opportunities-and-challenges-towards-an-evidence-and-rights-based-approach http://hdl.handle.net/10986/29964 |
| Summary: | Compulsory drug detention centers
(CDDCs) are common throughout Asia. However, medical
treatments for substance use disorders, such as opioid
agonist treatment (OAT), are generally unavailable in these
settings. In this report, the authors compare the
effectiveness of CDDCs with voluntary drug treatment centers
(VTCs) offering OAT in Malaysia. Positive urine drug testing
(UDT) after release confirmed opioid relapse in both groups.
Specifically, the authors measure the timing of relapse,
that is, the authors compare when patients that have been
discharged from CDDCs and VTCs relapse to opioid. The
authors conducted a study on opioid dependent individuals
from Malaysian CDDCs and VTCs from August 2012 to September
2014. Baseline (at the starting point of the study) and
semi-monthly behavioral assessments and UDTs were conducted
for up to one year after release and discharge. Relapse
rates between the groups were compared using advanced
statistical analysis. Screening occurred in 168 CDDC
attendees and 113 VTC in-patients, with 89 (CDDC), and 95
(VTC) of these individuals, respectively, having a baseline
interview and at least one UDT. The authors found that
opioid-dependent persons that have been released from CDDCs
relapse to opioid use significantly faster than those from
VTC services. This suggests the services provided by CDDCs
have little role in the treatment of opioid use disorders. |
|---|